PELLEGRINI, LUCA
PELLEGRINI, LUCA
Borsisti
Borderline personality disorder and aggressive behavior: A study based on the DSM-5 alternative model.
2024 Anna Caterina Leucci, Ilaria De Giorgi, Lorenzo Pelizza, Biancamaria Bortolotti, Francesca D'Adda, Lorenzo Gammino, Sara Gibiino, Loredana Lia, Margherita Magro, Luca Pellegrini, Marco Menchetti
Cognitive disturbances basic symptoms in help-seeking patients with borderline personality disorder: Characteristics and association with schizotypy.
2024 Lorenzo Gammino, Lorenzo Pelizza, Roberta Emiliani, Francesca D'Adda, Pasqualino Lupoli, Luca Pellegrini, Domenico Berardi, Marco Menchetti.
Emotion dysregulation, impulsivity and anger rumination in borderline personality disorder: the role of amygdala and insula
2024 Mitolo, M.; D’Adda, F.; Evangelisti, S.; Pellegrini, L.; Gramegna, L. L.; Bianchini, C.; Talozzi, L.; Manners, D. N.; Testa, C.; Berardi, D.; Lodi, R.; Menchetti, M.; Tonon, C.
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
2024 Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E.
Assessing suicide risk in patients with obsessive-compulsive disorder: a dimensional approach
2023 Bramante S.; Maina G.; Borgogno R.; Pellegrini L.; Rigardetto S.; Albert U.
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct
2023 Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E.
Feasibility, acceptability and practicality of transcranial stimulation in obsessive compulsive symptoms (FEATSOCS): A randomised controlled crossover trial
2023 Fineberg N.A.; Cinosi E.; Smith M.V.A.; Busby A.D.; Wellsted D.; Huneke N.T.M.; Garg K.; Aslan I.H.; Enara A.; Garner M.; Gordon R.; Hall N.; Meron D.; Robbins T.W.; Wyatt S.; Pellegrini L.; Baldwin D.S.
Healthcare Service Quality Evaluation in a Community-Oriented Primary Care Center, Italy
2023 Ceccarelli, Andrea; Minotti, Alice; Senni, Marco; Pellegrini, Luca; Benati, Giuseppe; Ceccarelli, Paola; Federici, Andrea; Mazzini, Silvia; Reali, Chiara; Sintoni, Francesco; Gori, Davide; Montalti, Marco
A preliminary investigation of Cyberchondria and its correlates in a clinical sample of patients with obsessive–compulsive disorder, anxiety and depressive disorders attending a tertiary psychiatric clinic
2022 Vismara M.; Benatti B.; Ferrara L.; Colombo A.; Bosi M.; Varinelli A.; Pellegrini L.; Vigano C.; Fineberg N.A.; Dell'Osso B.
Advances in problematic usage of the internet research – A narrative review by experts from the European network for problematic usage of the internet
2022 Fineberg N.A.; Menchon J.M.; Hall N.; Dell'Osso B.; Brand M.; Potenza M.N.; Chamberlain S.R.; Cirnigliaro G.; Lochner C.; Billieux J.; Demetrovics Z.; Rumpf H.J.; Muller A.; Castro-Calvo J.; Hollander E.; Burkauskas J.; Grunblatt E.; Walitza S.; Corazza O.; King D.L.; Stein D.J.; Grant J.E.; Pallanti S.; Bowden-Jones H.; Ameringen M.V.; Ioannidis K.; Carmi L.; Goudriaan A.E.; Martinotti G.; Sales C.M.D.; Jones J.; Gjoneska B.; Kiraly O.; Benatti B.; Vismara M.; Pellegrini L.; Conti D.; Cataldo I.; Riva G.M.; Yucel M.; Flayelle M.; Hall T.; Griffiths M.; Zohar J.
Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)
2022 Fineberg N.A.; Hollander E.; Grant J.E.; Chamberlain S.R.; Drummond L.M.; Pellegrini L.; Laws K.R.; Wellsted D.; Reid J.; Nezgovorova V.; Baldwin D.S.
Effects of exercise on obsessive-compulsive disorder symptoms: a systematic review and meta-analysis
2022 Bottoms L.; Prat Pons M.; Fineberg N.A.; Pellegrini L.; Fox O.; Wellsted D.; Drummond L.M.; Reid J.; Baldwin D.S.; Hou R.; Chamberlain S.; Sireau N.; Grohmann D.; Laws K.R.
Functional interventions as augmentation strategies for obsessive-compulsive disorder (OCD): scoping review and expert survey from the international college of obsessive-compulsive spectrum disorders (ICOCS)
2022 Varinelli A.; Caricasole V.; Pellegrini L.; Hall N.; Garg K.; Mpavaenda D.; Dell'Osso B.; Albert U.; Fineberg N.A.; Van Ameringen M.; Fontenelle L.; Grassi G.; Feusner J.; Carmi L.; Grunblatt E.; Walitza S.; Lochner C.; Rodriguez C.; Bystritsky A.; Rosario M.C.; van Roessel P.; Geller D.; Hollander E.; Nicolini H.; Zohar J.; Menchon J.
Individual obsessive-compulsive traits are associated with poorer adjustment to the easing of COVID-19 restrictions
2022 Fineberg N.A.; Pellegrini L.; Burkauskas J.; Clarke A.; Laws K.R.
Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design
2022 Fineberg N.A.; Pellegrini L.; Clarke A.; Perera U.; Drummond L.M.; Albert U.; Laws K.R.
New challenges in facing cyberchondria during the coronavirus disease pandemic
2022 Vismara M.; Varinelli A.; Pellegrini L.; Enara A.; Fineberg N.A.
Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications
2022 Pellegrini L.; Garg K.; Enara A.; Gottlieb D.S.; Wellsted D.; Albert U.; Laws K.R.; Fineberg N.A.
The Inflating Impact of Waiting-List Controls on Effect Size Estimates
2022 Laws K.R.; Pellegrini L.; Reid J.E.; Drummond L.M.; Fineberg N.A.
Facing the “new normal”: How adjusting to the easing of COVID-19 lockdown restrictions exposes mental health inequalities
2021 Fineberg N.A.; Pellegrini L.; Wellsted D.; Hall N.; Corazza O.; Giorgetti V.; Cicconcelli D.; Theofanous E.; Sireau N.; Adam D.; Chamberlain S.R.; Laws K.R.
Prevalence and correlates of current suicide risk in an international sample of OCD adults: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) network and Obsessive Compulsive and Related Disorders Network (OCRN) of the European College of Neuropsychopharmacology
2021 Benatti B.; Dell'Osso B.; Shen H.; Filippou-Frye M.; Varias A.; Sanchez C.; Jo B.; Hollander E.; Fineberg N.A.; Stein D.J.; Nicolini H.; Lanzagorta N.; Marazziti D.; Pallanti S.; Van Ameringen M.; Lochner C.; Karamustafalioglu O.; Hranov L.; Figee M.; Drummond L.; Grant J.E.; Denys D.; Fontenelle L.F.; Menchon J.M.; Zohar J.; Pellegrini L.; Rodriguez C.I.